Cell Therapeutics (CTIC) ADC Cell Therapeutics (18 lettori)

[ghiottolux]

Ciao Aragingo, avevo già dato uno sguardo ai due sec ieri intorno a mezzanotte, a parte il fatto che sono lunghi eterni ed il fatto che quello dei 150 milioni è al condizionale ed è simile a quello da 100 milioni emesso in settembre 2011 prima dell'assemblea degli azionisti, come si diceva ieri è inutile scervellarsi, l'unica cosa che voglio segnalare è che dopo l'uscita dei due sec qualcuno a pensato bene di comprare 2000 azioni, una miseria pagandole però il 22 % in ora se tutti oggi facessero la stessa cosa non sarebbe male, ma mi sembra una speranza un po' azzardata, ameno che non debba uscire qualcos'altro tra pochi minuti, anche perchè nel secondo sec 10-Q la società che fa un bel riassunto della situazione non mi sembra dica niente di nuovo.

 

[s66]

tanto di rispetto per voi che fate ricerca su questo titolo. MA A SEMBRA SEMPRE LA SOLITA SOLFA DI BIANCO E COMPANY. UNA RIFLESSIONE PERO' LA VOGLIO FARE:LA SOCIETA' SALI' A RAZZO NEL 2009 ?SOLO DOPO LA SOSPENSIONE DA PARTE DELL'AUTORITA' COMPETENTI (CONSOB,SEC)! X CUI A STO TRUFFATORE,BISOGNA TOGLIERGLI LA (PAZZIELLA) DALLE MANI PER OTTENERE QUALCOSA !

 

[*LEONIDA]

Buongiorno al forum,
effettivamente avete ragione è inutile andare a cercare qualche l'ago nel pagliaio tanto dobbiamo solo aspettare....
Sono davvero amareggiato ma allo stesso tempo ci sono situazioni serie e concrete sotto questa azienda... Sicuramente stanno guadagnando con lo short e con tutti i mezzi finanziari a loro disposizione, ma questo potrebbe essere il debito che bianco ha con tutti loro x aver avuto soldi x evitare il fallimento, quindi prima o poi avrà saldato tutto e allora vedremo....io continuo a crederci e personalmente se dovesse rimanere a questi prezzi a fine mese riesco a prenderne altre 10 mila ..
saluti a tutti voi ..
ciao mici e sig. Aragingo buon lavoro

 

[ghiottolux]

Sec filing delle 12 e 30

Perchè pietire in questo modo il voto in Italia? quant'è il quorum? sonocosì tante le azioni in Italia?

SEC FILING | Cell Therapeutics, Inc. Form DEFA14A

 

[CELLISTA DOC]

Secondo me le Azioni in Italia sono tante, azzardo un numero (guardatelo con simpatia anche se solo un azzardo) 100 mln.
Poco fa è stato emesso un nuovo Sec datato 03/08 che confermerebbe detto azzardo.
Dall'S. 3, varie considerazioni a parte, la parte più interessante mi smbra la seguente:

General​

We are authorized to issue 383,333,333 shares of common stock, no par value, and 1,666,666 shares of preferred stock, no par value. In our proxy
statement for the 2012 annual meeting of our shareholders, we have included a proposal to increase the total number of authorized shares from 384,999,999 to
751,666,666 and the total number of authorized shares of common stock from 383,333,333 to 750,000,000 shares. As of July 31, 2012, there were
283,408,995 shares of common stock outstanding, warrants to purchase approximately 65,230,425 shares of common stock outstanding and no shares of
preferred stock outstanding. In addition, as of July 31, 2012, 4,557,049 shares of common stock were reserved for issuance under our equity compensation
plans, 217,818 shares of common stock were reserved for issuance under our employee stock purchase plan and 65 shares of common stock were reserved for
issuance upon exercise of outstanding restricted share rights.
On April 15, 2007, we effected a one-for-four reverse stock split of our common stock, on August 31, 2008, we effected a one-for-ten reverse stock
split of our common stock and on May 15, 2011, we effected a one-for-six reverse stock split of our common stock.
On June 29, 2012, we received a notice from NASDAQ stating that, based on the closing bid price of our common stock for the thirty (30) consecutive
business days preceding such date, we no longer met the minimum $1.00 per share requirement for continued listing on The NASDAQ Capital Market. In
accordance with NASDAQ Listing Rule 5810(c)(3)(A), we were provided a grace period of one hundred eighty (180) calendar days, or until December 26,
2012, to regain compliance. We may achieve compliance during the 180-day period if the closing bid price of our common stock is at least $1.00 per share for
a minimum of ten (10) consecutive trading days before December 26, 2012. We may be eligible for an additional grace period if we meet the initial listing
standards, with the exception of bid price, for The NASDAQ Capital Market. If we meet the initial listing criteria, with the exception of bid price, we may be
granted an additional 180 calendar day compliance period.
As of August 2, 2012, the closing bid price of our common stock for the last thirty (30) days has been below $1.00 per share. If we are unable to attain
compliance with the minimum bid price requirement, whether by effectuating a reverse stock split of our common stock or otherwise, our common stock may
be delisted from The NASDAQ Capital Market. To address our non-compliance with the minimum bid price requirement, our board of directors may
determine in its discretion that we should complete a reverse stock split, which may be implemented prior to December 26, 2012, or the Reverse Stock Split.
If our board of directors approves the Reverse Stock Split, then all of the outstanding and authorized shares of the Company's common stock immediately
prior to the effective date of the Reverse Stock Split, or the Effective Date, will be reduced in proportion to the ratio of the Reverse Stock Split. In such event,
proportionate adjustments would also be made to our outstanding equity awards, as well as the number of shares of our common stock available for award
grants under our 2007 Equity Incentive Plan, as amended and restated. There can be no assurance that the Reverse Stock Split will have the intended effect or
that any increase in the trading price of our common stock will be proportional to the decrease in the number of outstanding shares.
5​

Table of Contents​

We currently expect that if the Reverse Stock Split is implemented, it will have a ratio of between one-for-three and one-for-five. However, our board
of directors may approve the Reverse Stock Split with a ratio above or below that range. If we implement a one-for-three Reverse Stock Split, then on the
Effective Date, each shareholder will receive one new share of our common stock in exchange for every three shares of our common stock such shareholder
holds. If we implement a one-for-four Reverse Stock Split, then on the Effective Date, each shareholder will receive one new share of our common stock in
exchange for every four shares of our common stock such shareholder holds. If we implement a one-for-five Reverse Stock Split, then on the Effective Date,
each shareholder will receive one new share of our common stock in exchange for every five shares of our common stock such shareholder holds. The
Reverse Stock Split would affect all outstanding and authorized shares of our common stock as well as the number of shares of common stock underlying
stock options and other exercisable or convertible instruments outstanding on the Effective Date.​

Common Stock​

Each holder of common stock is generally entitled to one vote for each share held on all matters to be voted upon by the shareholders and there are no
cumulative voting rights. Subject to preferences that may be applicable to any outstanding preferred stock, holders of common stock are entitled to receive
ratably the dividends, if any, that are declared from time to time by the board of directors out of funds legally available for that purpose. In the event of our
liquidation, dissolution or winding up, the holders of common stock are entitled to share in our assets remaining after the payment of liabilities and the
satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. Holders of common stock have no preemptive or
conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of
common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely
affected by, the rights of the holders of shares of any series of preferred stock that we may designate in the future.​

General Description of Preferred Stock​

Our board of directors has the authority, without action by the shareholders, to designate and issue preferred stock in one or more series and to
designate the rights, preferences and privileges of each series, which may be greater than the rights of the common stock. The prospectus supplement relating
to the series of preferred stock offered by that supplement will describe the specific terms of those securities. It is not possible to state the actual effects of the
issuance of any shares of preferred stock upon the rights of holders of the common stock until our board of directors determines the specific rights of the
holders of such preferred stock. However, the effects could include, among other things:
• restricting dividends on the common stock;
• diluting the voting power of the common stock;
• impairing the liquidation rights of the common stock; or
• delaying or preventing a change in control of the Company without further action by the shareholders.​

Anti-Takeover Effects of Provisions of Washington Law, Our Articles of Incorporation and Bylaws and Our Rights Plan​

Washington law contains certain provisions that may have the effect of delaying, deterring or preventing a change in control of the Company. Chapter
23B.19 of the Washington Business Corporation Act prohibits us, with certain exceptions, from engaging in certain significant business transactions with an
"acquiring person" (defined generally as a person or group of persons who acquire 10% or more of our voting securities) for a period of five years following
the acquiring person's share acquisition date. The prohibited transactions include, among others, a merger or consolidation with, disposition of assets to, or
issuance or redemption of stock to or from, the acquiring person, or any other receipt by the acquiring person of a disproportionate benefit as a shareholder.
Exceptions to this statutory prohibition include approval of the transaction at a shareholders meeting by holders of not less than two-thirds of the outstanding
shares entitled to vote on the transaction, not counting shares as to which the acquiring​

6

Ragioniamoci sopra, dai numeri mi sembra di poter concludere che le azioni disponibili alla vendita, con il 31/07 sono esaurite. Non solo, ma CTIC non ha neppure la disponibilità delle Azioni a servizio dei Warrants comunicati con l'esercizio dei 15 mln $ della serie 15.2. A conferma di ciò, nel comunicato si impegna a regolarle con un rimborso cash mediante un pagherò a 1 anno.
Sui 150 mln di $. in azioni, al condizionale, dove le prende ?
Sarebbero disponibili solo ed esclusivamente se il 31/08 approvano l'incremento a 750 mln !
Buon giorno al Forum.

 

[aragingo]

Ode a J. B. (Bill Joe)

Dopo gli interminabili scritti che ci dispensa la ditta Cell, posso dirvi che sono stanco di leggerli, come credo molti di voi.

Nasce spontanea una considerazione.
Pochissimi di noi sarebbero investiti in Cell se non avessimo avuto il botto nell'estate 2009.
Ragionate!
O perchè se n'è beneficiato (il mio caso) o perchè si è assistito alla fortuna altrui e come pecoroni non si è incamerato il gain (caso di tanti miei "eroici" conoscenti: "noi eroicamente resistiamo!"), abbiamo avuto la prova provata che con questo titolo si può fare il botto.
In qualità di analista, terra terra, credetemi questa è l'unica ragione per la quale seguiamo questo titolo.

E' come quello che va a pescare per la prima volta e prende una mormora di 2 chili. Starà un anno ad uscire in barca ogni sera, non prenderà un cacchio, ma sarà sempre lì con l'immagine di quel pesce che prese e che spera ce ne sia ancora un altro nei paraggi.

 

[AV65]

Ben detto Aragingo!

E' proprio così...pure il sottoscritto...intorno alla metà di marzo 2009, per quanto mi riguarda la mia settimana da "leoni", ricordo molto bene il gain che feci!!!
Ed ora ci sono dentro...

Saluti

 

[AV65]

...e speriamo ancora per il futuro!!!
CTI ci darà ancora soddisfazioni (ma nel frattempo qualche "sofferenza")!
Entro fine anno...

Saluti

 

[tazio55]

ho trovato questo Socius Capital Group LLC.

 

[s66]

se sia vera questa storia che in italia siano in mano 100mln di azioni ? SAREBBE BENE CHE LA CONSOB PRENDESSE PROVVEDIMENTI SERI ! NON ESISTE FAR PASSARE QUESTO FURTO CONTINUATO COME NULLA FOSSE ! QUESTI AMERICANI DEVONO ESSERE CACCIATI FUORI !